Ticker: PH

Parker Hannifin

Industrials Industrials Industrial - Machinery

Price 880.57

Reco Sell Potential 37 Risk 77 Updated 2026-10-25

Official website

Forecast impact

negative

Target +13.8% target fill 87.9%

Reaction D5 pending · D10 pending market trust

Impact Potential -4 · Risk +3 valid until 2026-11-18

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell

Description

Company and Business Model

Parker Hannifin Corporation is a global leader in motion and control technologies. The company designs and manufactures a wide range of products, including hydraulic, pneumatic, and electromechanical systems, as well as filtration and sealing solutions. Its major business segments include Industrial, Aerospace, and Climate & Industrial Controls, with primary revenue sources stemming from manufacturing and servicing equipment for various industries such as aerospace, automotive, and energy.

Investment Profile

The investment profile of Parker Hannifin is more aligned with balanced investors, given its moderate dividend yield and stable revenue growth. The company demonstrates resilience in its operations, making it suitable for those seeking a combination of income and capital appreciation. The stock's performance reflects a cautious approach, appealing to investors with a medium to long-term horizon who prefer a balanced risk-return profile.

Category: Industrials Sector: Industrials Industry: Industrial - Machinery Investment style: Growth Horizon: Medium-term Company type: Blue Chip Company type: Market Leader

Fundamental metrics (experimental) Updated: 2026-10-21

EPS (TTM) — earnings per share for the last 12 months, $: 28.90
Revenue QoQ — quarter-over-quarter revenue growth: 4.9%
EPS surprise: 11.6%
20d volatility: 1.1%
Dividend yield: 0.8%
last ex-date: 2026-08-31

AI recommendation changes

Date	Before	After	Reason
2026-10-23	Hold	Sell	Weak momentum and high risk overshadow fundamentals.
2026-10-13	Buy	Hold	Mixed performance; cautious outlook amid market uncertainties.
2026-09-26	Hold	Buy	Strong fundamentals and positive momentum support growth potential.
2026-09-19	Sell	Hold	Mixed performance; cautious outlook amid market conditions.
2026-09-10	Buy	Sell	Weak momentum and high risk overshadow potential upside.
2026-09-04	Sell	Buy	Mixed momentum; fundamentals show promise but uncertainty remains.
2026-09-02	Buy	Sell	Weak momentum and high risk limit upside potential.
2026-08-01	Sell	Buy	Solid fundamentals, but mixed momentum signals present uncertainty.
2026-07-30	Buy	Sell	Weak momentum and high risk; hold for now.
2026-07-27	Hold	Buy	Solid fundamentals, but mixed momentum signals.
2026-07-19	Buy	Hold	Mixed performance; cautious outlook amid market conditions.
2026-07-11	Hold	Buy	Solid fundamentals, but mixed momentum signals present uncertainty.
2026-07-09	Buy	Hold	Mixed performance; cautious outlook amid market volatility.
2026-06-13	Hold	Buy	Solid fundamentals, but mixed momentum signals present uncertainty.
2026-06-05	Sell	Hold	Mixed performance; cautious outlook amid market volatility.
2026-05-22	Hold	Sell	Weak momentum and high risk overshadow potential upside.
2026-05-08	—	Hold	Weak momentum and high risk; hold for now.
2026-05-02	Buy	Hold	Компания демонстрирует умеренный рост выручки и положительный сюрприз по EPS, однако недавние колебания цен и высокая волатильность указывают на значительные риски.
2026-03-29	Buy	Hold	Компания демонстрирует стабильный рост выручки и положительный сюрприз по прибыли, однако недавнее снижение цены акций и высокая волатильность могут указывать на определенные риски.
2026-03-17	Hold	Buy	Компания показывает стабильный рост за последние 120 дней, однако недавнее снижение цен на 10.69% за 20 дней вызывает опасения. Низкая дивидендная доходность также может ограничивать привлекательность для инвесторов.
2026-03-09	Buy	Hold	Компания демонстрирует стабильный рост за последние 120 дней, однако недавнее снижение цен и волатильность на рынке могут указывать на краткосрочные риски. Рекомендуется удерживать акции до более ясных сигналов о восстан
2026-01-30	Hold	Buy	Компания демонстрирует сильный рост за последние месяцы, что указывает на позитивные перспективы. Тем не менее, отсутствие данных по EPS и дивидендам требует осторожности.
2026-01-29	Buy	Hold	Компания показала сильный рост за последние 120 дней, однако недавние колебания цен и отсутствие данных по EPS и дивидендам создают неопределенность. Рекомендуется удерживать акции до получения более ясной информации.

Analyst forecasts

Date	Analyst	Action	Target	Price Then
2026-10-19	Stifel Nicolaus	Target Lowered	1075 → 1002	963.34
2026-10-15	Mizuho Securities	Target Lowered	1285 → 1200	956.32
2026-10-14	UBS	Target Raised	— → 950	960.6
2026-09-24	Wells Fargo	Update	— → 1050	974.98
2026-08-14	Bernstein	Target Raised	1037 → 1218	1057.28
2026-08-07	Truist Financial	Target Raised	1269 → 1358	1079.69
2026-08-07	Stifel Nicolaus	Target Raised	1000 → 1075	1081.58252
2026-08-07	BMO Capital	Target Raised	1090 → 1214	1069.8
2026-08-07	UBS	Target Raised	— → 1250	1069.8
2026-08-07	KeyBanc	Target Raised	1100 → 1210	1069.8
2026-07-16	Bernstein	Target Raised	— → 1037	973.1
2026-07-02	Truist Financial	Target Raised	1147 → 1269	963.81
2026-06-09	Bernstein	Update	— → 1026	905.53
2026-05-26	Wells Fargo	Target Lowered	980 → 950	866.96
2026-05-11	Evercore ISI	Target Lowered	1168 → 1064	870.1
2026-05-01	Truist Financial	Target Raised	1139 → 1147	889.27
2026-05-01	Mizuho Securities	Target Raised	950 → 1050	895.3
2026-04-10	Stifel Nicolaus	Target Raised	965 → 1000	983.17
2026-03-26	BMO Capital	Update	— → 1090	901.46
2026-02-24	Morgan Stanley	Target Raised	945 → 1038	1018.77
2026-01-30	Truist Financial	Target Raised	1097 → 1139	936.195
2026-01-30	KeyBanc	Target Raised	1050 → 1100	948.4
2026-01-30	Stifel Nicolaus	Target Raised	941 → 965	948.4

News Page 1 of 1

Trivector Research Recommends Investing in 'Non-Tech Compounders' for Strong Returns Beyond AI

08/10/2026, 12:39 PM investing research healthcare consumer Tapestry Parker Hannifin Eli Lilly

Investors are encouraged to consider 'non-tech compounders' as a strategy to diversify portfolios amid market volatility driven by AI and semiconductor stocks. Trivector Research identifies these companies as having strong growth potential without the risks associated with crowded trades in the tech sector.